Chemical Structure : NEO2734
CAS No.: 2081072-29-7
货号: PC-38169Not For Human Use, Lab Use Only.
NEO2734 (NEO-2734, EP31670) is a dual inhibitor of pan-BET and CBP/p300 with Kd values of 2-31 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1580 | In stock | |
10 mg | ¥2480 | In stock | |
25 mg | ¥3980 | In stock | |
50 mg | ¥5980 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NEO2734 (NEO-2734, EP31670) is a dual inhibitor of pan-BET and CBP/p300 with Kd values of 2-31 nM.
NEO2734 exhibited in vitro antitumor activity in a variety of cancer cell lines derived from different tumor types, especially from prostate cancer, leukemias, and lymphomas.
NEO2734 showed a clear in vitro antitumor activity in DLBCL, which was more potent than either a BET inhibitor (birabresib) or a CBP/EP300 inhibitor (SGC-CBP30).
NEO2734 is active in both hotspot mutant (F133V) and non-hotspot mutant (Q165P) PCa cells in vitro and in vivo.
分子量 | 435.447 | |
分子式 | C22H24F3N3O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1,3-dimethyl-5-(2-(tetrahydro-2H-pyran-4-yl)-1-(2-(trifluoromethoxy)ethyl)-1H-benzo[d]imidazol-6-yl)pyridin-2(1H)-one |
1. Yan Y, et al. EMBO Mol Med. 2019 Nov 7;11(11):e10659.
2. Spriano F, et al. Blood Adv. 2020 Sep 8;4(17):4124-4135.
3. Morrison-Smith CD, et al. Mol Cancer Ther. 2020 Jul;19(7):1406-1414.
4. He Y, et al. Nat Commun. 2021 Mar 9;12(1):1521.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright